| Head and Neck Cancer |
1 |
1 |
| Generics |
0 |
0.73 |
| Otolaryngology |
0 |
0.71 |
| Oral and Pharyngeal Cancer |
0 |
0.99 |
| Cancer |
0 |
0.52 |
| Biologic Therapy |
0 |
0.48 |
| Antineoplastic Drug |
0 |
0.44 |
| Medicare |
0 |
0.39 |
| Leukemia |
0 |
0.37 |
| Grant |
0 |
0.07 |
| Health Care Economics |
0 |
0.97 |
| Insurance |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Medicaid |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.98 |
| Social Determinants of Health |
0 |
0.07 |
| Tyrosine Kinase Inhibitor |
0 |
0.07 |